by Jordana Choucair | May 11, 2022 | Opioid/Substance Use Disorders
Join Third Horizon Strategies Managing Director Greg Williams on June 7 for a Tech Talk examining tech requirements for value-based care for behavioral health and substance use disorder (SUD) providers. Greg and Hans Morefield, CEO of CHESS Health, will discuss...
by Jordana Choucair | May 11, 2022 | Payers
Oscar Health said it will exit Colorado and Arkansas after the company failed to attract members in those states. During its first-quarter earnings call, Chief Financial Officer Scott Blackley said that the insurtech does not expect the move to have a...
by Jordana Choucair | May 11, 2022 | Public Health/Prevention
New research from the Centers for Disease Control and Prevention (CDC) shows that the rate at which Americans were killed in gun homicides soared by nearly 35 percent in 2020 to the highest level in more than 25 years. Amid the pandemic and recession that followed,...
by Jordana Choucair | May 10, 2022 | Access & Coverage
A new Kaiser Family Foundation analysis found that between 5.3 million and 14.2 million people could lose their health coverage when temporary pandemic-inspired reforms to Medicaid expire at the end of the public health emergency. The biggest losses are expected to be...
by Jordana Choucair | May 10, 2022 | D.C. News
Congressional Democrats will pursue additional pandemic response funding and Ukrainian aid separately after President Joe Biden said pairing the two measures in one package would delay the “urgently needed” funding to Ukraine. The president also encouraged...
by Jordana Choucair | May 10, 2022 | M&A
Pfizer Inc. said it will spend about $11.6 billion to buy the rest of Biohaven Pharmaceutical Holding Co., which makes the prescription migraine drug Nurtec. The deal, which is expected to be completed by early 2023, will give Pfizer full ownership of Biohaven after...
Recent Comments